ASB vs CME
Associated Bank vs CME Group — AI-powered side-by-side comparison
ASB
Associated Bank
69
Buy
VS
| Metric | ASB | CME |
|---|
| AI Score |
69
|
63
|
| Price |
$30.85
|
$281.06
|
| P/E Ratio |
10.66×
|
23.40×
|
| ROE |
9.5%
|
14.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
60.5%
|
81.9%
|
| Debt / Equity |
1.01×
|
0.13×
|
| Dividend Yield |
3.1%
|
4.1%
|
| RSI (14) |
35.9
|
68.7
|
| Beta |
0.771
|
0.267
|
| Expected Upside |
—
|
+3.7%
|
AI Committee View
Current Innellis committee reasoning for ASB versus CME.
ASB leads by 6 points.
ASB scores 69/100 (Buy) versus CME at 63/100 (Buy).
ASB Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- P/E of 12.0 is inexpensive for the broad market — Value
- Price-to-book of 0.9x is a discount to asset value — Value
- Dividend yield of 5.0% pays you to wait — Value
Bear Case
- MACD histogram negative -- bearish momentum — Technical
CME Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.12) -- balance sheet can absorb a shock. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 15.6% shows genuine earnings power backing the valuation — Value
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth